問卷

TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation (在職)

Division of Dermatology

Division of Others-Immunodermatology, Adverse drug reactions, Drug hypersensitivity, Pharmacogenomics

Division of General Internal Medicine

Taipei Chang Gung Medical Foundation (在職)

Division of Dermatology

Division of Others-Immunodermatology, Adverse drug reactions, Drug hypersensitivity, Pharmacogenomicspsoriasis,

更新時間:2023-10-24

鐘文宏Chung, Wen-Hung
  • Principal Investigator
  • Clinical Trial Experience (year) 17 years 9 個月
  • chung1@cgmh.org.tw

Publication

82Publications

71

12. Pan RY, Chung WH, Chu MT, Chen SJ, Chen HC, Zheng L, Hung SI. Recent Development Clinical Application of Cancer Vaccine: Targeting Neoantigens. J Immunol Res. 2018 Dec 19;2018:4325874. doi: 10.1155/2018/4325874. eCollection 2018. (co-first author) (SCI; IF=3.276; Immunology: 63/151)

72

11. Wang YH, Chen CB, Tassaneeyakul W, Saito Y, Aihara M, Choon SE, Lee HY, Chang MM, Roa FD, Wu CW, Zhang J, Nakkam N, Konyoung P, Okamoto-Uchida Y, Man-Tung Cheung C, Huang JW, Ji C, Cheng B, Chung-Yee Hui R, Chu CY, Chen YJ, Wu CY, Hsu CK, Chiu TM, Ho HC, Lin JY, Yang CH, Chang YC, Su SC, Wang CW, Chung WH*; Asian Severe Cutaneous Adverse Reaction Consortium. The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison to the USA FDA Label. Clin Pharmacol Ther. 2019 Jan;105(1):112-120. (SCI; IF=7.268; Pharmacology & pharmacy: 10/255)

73

10. Su SC, Chen CB, Chang WC, Wang CW, Fan WL, Lu LY, Nakamura R, Saito Y, Ueta M, Kinoshita S, Sukasem C, Yampayon K, Kijsanayotin P, Nakkam N, Saksit N, Tassaneeyakul W, Aihara M, Lin YJ, Chang CJ, Wu T, Hung SI, Chung WH*. HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians. Clin Pharmacol Ther. 2019 Feb;105(2):476-485. (SCI; IF=7.268; Pharmacology & pharmacy: 10/255)

74

9. Phillips EJ, Bigliardi P, Bircher AJ, Broyles A, Chang YS, Chung WH, Lehloenya R, Mockenhaupt M, Peter J, Pirmohamed M, Roujeau JC, Shear NH, Tanno LK, Trubiano J, Valluzzi R, Barbaud A. Controversies in drug allergy: Testing for delayed reactions. J Allergy Clin Immunol. 2019 Jan;143(1):66-73. (SCI; IF=12.485; Allergy: 1/25; Immunology: 5/151)

75

8. Mockenhaupt M, Wang CW, Hung SI, Sekula P, Schmidt AH, Pan RY, Chen CB, Dunant A, Gouvello SL, Schumacher M, Valeyrie-Allanore L, Bellon T, Kardaun SH, Jan YS, Chung WH*, Roujeau JC; RegiSCAR group. HLA-B*57:01 confers genetic susceptibility to carbamazepine-induced SJS/TEN in Europeans. Allergy. 2019 Apr 11. doi:10.1111/all.13821. [Epub ahead of print] PubMed PMID: 30972788. (SCI; IF=6.771)

76

7. Tsai YG, Liou JH, Hung SI, Chen CB, Chiu TM, Wang CW, Chung WH*. Increased Type 2 Innate Lymphoid Cells in Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome. J Invest Dermatol. 2019 Aug;139(8):1722-1731. (SCI; IF=6.290)

77

6. Pan RY, Chu MT, Wang CW, Lee YS, Lemonnier F, Michels AW, Schutte R, Ostrov DA, Chen CB, Phillips EJ, Mallal SA, Mockenhaupt M, Bellón T, Tassaneeyakul W, White KD, Roujeau JC, Chung WH*, Hung SI*. Identification of drug-specific public TCR driving severe cutaneous adverse reactions. Nat Commun. 2019 Aug 8;10(1):3569. (SCI; IF=11.878)

78

5. Chen CH, Chen CB, Chang CJ, Lin YJ, Wang CW, Chi CC, Lu CW, Chen WT, Pan RY, Su SC, Hsu LA, Chang YC, Yu KH, Wu YJ, Lin KM, Hung SI, Chen SM*, Chung WH*. Hypersensitivity and Cardiovascular Risks Related to Allopurinol and Febuxostat Therapy in Asians: A Population-Based Cohort Study and Meta-Analysis. Clin Pharmacol Ther. 2019 Aug;106(2):391-401. (SCI; IF=6.336)

79

4. Lu KL, Wu MY, Wang CH, Wang CW, Hung SI, Chung WH*, Chen CB*. The Role of Immune Checkpoint Receptors in Regulating Immune Reactivity in Lupus. Cells. 2019 Oct 8;8(10). (SCI; IF=5.656)

80

3. Chen CB, Kuo KL, Wang CW, Lu CW, Chung-Yee Hui R, Lu KL, Chang WC, Chen WT, Yun F, Teng YC, Lee HE, Lin JY, Ho HC, Chi MH, Yu-Wei Lin Y, Chang CJ, Lin Y Jr, Ku CL, Hung SI, Chang YC, Chung WH*. Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocyte-Mediated Bullous Skin Disorders. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1327-1337.e3. (SCI; IF=8.861)